GeneOne Life Science

011000 · KOSPI · Health Care · SMALL CAP

An acquisition.

GeneOne Life Science disclosed an acquisition, worth US$2.03M.

M&A(Decision to acquire shares/equity in another company)· FILED 2026-04-14· RCEPT 20260414800718

US$2.03MDeal value
2.5%vs. company assets

Converted at 1 USD ≈ ₩1,469.42 (filing-date rate, 2026-04-14 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-06-15) →

What happened

GeneOne Life Science disclosed an acquisition, worth US$2.03M.

For context, this deal is worth about 2.5% of the company's own total assets.

TargetDisclosed
Deal valueUS$2.03M
vs. company assets2.5%
Filed2026-04-14, Decision to acquire shares/equity in another company
SourceDART rcept 20260414800718 → open original filing

Versions of this filing

  1. 2026-04-14Original (this page)
  2. 2026-04-30Amendment 1
  3. 2026-05-15Amendment 2
  4. 2026-06-15Amendment 3

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-04-14 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.